Immunyx Pharma
Immune Modulation
StartupImmunyx Pharma is a Jerusalem-based startup in the Health Tech & Life Sciences sector, established in 2021. Immune Modulation. Immunyx Pharma was founded by Seth Salpeter. Key investors include VLX Ventures. The company has 1-10 employees. Core technologies: Biologicals.
The company follows a B2B business model. Product stage: R&D.
- StageSeed
- ProductR&D
- ModelB2B
- Employees1-10
- HQJerusalem
- DistrictJerusalem District
- Last RoundUndisclosed
- VLX Ventures
Seth SalpeterCo-founder & CEO
What does Immunyx Pharma do?
Immunyx Pharma is a drug development company focused on modulating neutrophil function to treat disease. Using the company's platform technology to specifically manipulate neutrophils using a targeted nanoparticle, Immunyx will bring new therapies to several diseases where neutrophil treatment could advance a cure. Immunyx Pharma's neutrophil-targeting technology is based on years of basic and translational research by professors Zvika Granot and Zvi Fridlender at the Hebrew University.
Who founded Immunyx Pharma?
Immunyx Pharma was founded in 2021 by Seth Salpeter (Co-founder & CEO).
What sector is Immunyx Pharma in?
Immunyx Pharma operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drugs Discovery & Development, with core technologies in Biologicals. Target customers: Healthcare & Life Sciences, Life Sciences, Pharmaceuticals.
Where is Immunyx Pharma located?
Immunyx Pharma is based in Jerusalem, Israel, Jerusalem District.